SEC Form 4 |
Date |
Sym |
Company |
Insider |
Title |
Shares |
Transaction |
Value |
|---|---|---|---|---|---|---|---|---|
Apr 30 2013 | PCYC | Pharmacyclics Inc | Loury David J | Chief Scientific Officer | 164 | Other Purchase at $10.56 | $1,731 | |
Feb 5 2013 | PCYC | Pharmacyclics Inc | Loury David J | Chief Scientific Officer | 20,000 | Option exercise at $2.76 | $55,200 | |
Feb 5 2013 | PCYC | Pharmacyclics Inc | Loury David J | Chief Scientific Officer | 20,000 | Sale at $70.58 | $1,411,510 | |
MJan 9 2013 | PCYC | Pharmacyclics Inc | Loury David J | Chief Scientific Officer | 21,062 | Sale at $35.23 | $742,014 | |
Jan 8 2013 | PCYC | Pharmacyclics Inc | Loury David J | Chief Scientific Officer | 10,000 | Option exercise at $4.16 | $41,600 | |
Jan 8 2013 | PCYC | Pharmacyclics Inc | Loury David J | Chief Scientific Officer | 10,000 | Sale at $64.70 | $647,000 | |
Dec 20 2012 | PCYC | Pharmacyclics Inc | Loury David J | Chief Scientific Officer | 39,469 | Option exercise at $4.16 | $164,191 | |
Dec 20 2012 | PCYC | Pharmacyclics Inc | Loury David J | Chief Scientific Officer | 39,469 | Sale at $61.12 | $2,412,274 | |
Oct 31 2012 | PCYC | Pharmacyclics Inc | Loury David J | Chief Scientific Officer | 163 | Other Purchase at $10.56 | $1,721 | |
Apr 30 2012 | PCYC | Pharmacyclics Inc | Loury David J | Chief Scientific Officer | 162 | Other Purchase at $10.56 | $1,710 | |
Oct 31 2011 | PCYC | Pharmacyclics Inc | Loury David J | Chief Scientific Officer | 3,227 | Other Purchase at $1.61 | $5,184 | |
Apr 29 2011 | PCYC | Pharmacyclics Inc | Loury David J | Chief Scientific Officer | 10,000 | Other Purchase at $1.61 | $16,065 | |
Oct 29 2010 | PCYC | Pharmacyclics Inc | Loury David J | Chief Scientific Officer | 10,000 | Other Purchase at $1.61 | $16,065 | |
Oct 30 2009 | PCYC | Pharmacyclics Inc | Loury David J | VP of Development | 1,000 | Other Purchase at $1.06 | $1,063 |